fingolimod hydrochloride has been researched along with Tonsillar Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, MD; Bozzetti, S; Gajofatto, A; Gobbin, F; Marangi, A; Mocella, S; Pea, M; Turatti, M | 1 |
1 other study(ies) available for fingolimod hydrochloride and Tonsillar Neoplasms
| Article | Year |
|---|---|
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod.
Topics: Carcinoma, Squamous Cell; Fingolimod Hydrochloride; Human papillomavirus 16; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Papillomavirus Infections; Tonsillar Neoplasms | 2018 |